WallStreetZenWallStreetZen

NYSE: NVS
Novartis Ag Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NVS

Based on 1 analyst offering 12 month price targets for Novartis Ag

Min Forecast
$118.00-27.46%
Avg Forecast
$118.00-27.46%
Max Forecast
$118.00-27.46%

Should I buy or sell NVS stock?

Based on 1 analyst offering ratings for Novartis Ag.

Strong Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 100%
Although NVS's forecast from analysts indicates a "Strong Sell", our proven Zen Rating quant model rates NVS as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their NVS stock forecasts and price targets.

NVS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-12Find Out Why

1 of 1

Forecast return on equity

Is NVS forecast to generate an efficient return?

Company
47.88%
Industry
-25.3%
Market
236.88%
NVS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NVS forecast to generate an efficient return on assets?

Company
19.91%
Industry
25.32%
NVS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NVS earnings per share forecast

What is NVS's earnings per share in the next 3 years based on estimates from 26 analysts?

Avg 1 year Forecast
$9.33+29.37%
Avg 2 year Forecast
$10.00+38.71%
Avg 3 year Forecast
$11.17+54.91%
NVS's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

NVS revenue forecast

What is NVS's revenue in the next 3 years based on estimates from 28 analysts?

Avg 1 year Forecast
$58.2B+2.65%
Avg 2 year Forecast
$60.9B+7.53%
Avg 3 year Forecast
$64.3B+13.48%
NVS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NVS earnings growth forecast

How is NVS forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
15.02%
Industry
26.47%
Market
39.25%
NVS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NVS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NVS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NVS revenue growth forecast

How is NVS forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
4.23%
Industry
7.99%
Market
23.93%
NVS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NVS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NVS vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
NVS$162.67$118.00-27.46%Strong Sell
AZN$204.20N/AN/A
MRK$122.26$122.36+0.08%Buy
ABBV$224.81$252.60+12.36%Strong Buy
AMGN$374.75$353.64-5.63%Buy
View Top General Drug Manufacturer Stocks

Novartis Ag Stock Forecast FAQ

Is Novartis Ag Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: NVS) stock is to Strong Sell NVS stock.

Out of 1 analyst, 0 (0%) are recommending NVS as a Strong Buy, 0 (0%) are recommending NVS as a Buy, 0 (0%) are recommending NVS as a Hold, 0 (0%) are recommending NVS as a Sell, and 1 (100%) are recommending NVS as a Strong Sell.

If you're new to stock investing, here's how to buy Novartis Ag stock.

What is NVS's earnings growth forecast for 2026-2028?

(NYSE: NVS) Novartis Ag's forecast annual earnings growth rate of 15.02% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 26.47%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.25%.

Novartis Ag's earnings in 2026 is $13,984,000,000.On average, 26 Wall Street analysts forecast NVS's earnings for 2026 to be $17,797,903,156, with the lowest NVS earnings forecast at $15,432,939,965, and the highest NVS earnings forecast at $19,414,489,258. On average, 23 Wall Street analysts forecast NVS's earnings for 2027 to be $19,083,806,572, with the lowest NVS earnings forecast at $15,915,511,524, and the highest NVS earnings forecast at $21,037,372,261.

In 2028, NVS is forecast to generate $21,312,146,103 in earnings, with the lowest earnings forecast at $19,129,983,843 and the highest earnings forecast at $25,445,202,639.

What is NVS's revenue growth forecast for 2026-2028?

(NYSE: NVS) Novartis Ag's forecast annual revenue growth rate of 4.23% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 7.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.93%.

Novartis Ag's revenue in 2026 is $56,674,000,000.On average, 28 Wall Street analysts forecast NVS's revenue for 2026 to be $111,004,815,774,146, with the lowest NVS revenue forecast at $101,017,549,886,260, and the highest NVS revenue forecast at $118,895,022,966,811. On average, 28 Wall Street analysts forecast NVS's revenue for 2027 to be $116,288,487,773,297, with the lowest NVS revenue forecast at $103,084,078,154,617, and the highest NVS revenue forecast at $125,384,646,827,090.

In 2028, NVS is forecast to generate $122,718,958,931,527 in revenue, with the lowest revenue forecast at $99,437,600,296,048 and the highest revenue forecast at $135,513,115,939,222.

What is NVS's forecast return on assets (ROA) for 2026-2029?

(NYSE: NVS) forecast ROA is 19.91%, which is lower than the forecast US Drug Manufacturers - General industry average of 25.32%.

What is NVS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NVS price target, the average NVS price target is $118.00, with the highest NVS stock price forecast at $118.00 and the lowest NVS stock price forecast at $118.00.

The Wall Street analyst predicted that Novartis Ag's share price could fall to $118.00 by Sep 12, 2026. The average Novartis Ag stock price prediction forecasts a potential downside of 27.46% from the current NVS share price of $162.67.

What is NVS's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: NVS) Novartis Ag's current Earnings Per Share (EPS) is $7.21. On average, analysts forecast that NVS's EPS will be $9.33 for 2026, with the lowest EPS forecast at $8.09, and the highest EPS forecast at $10.17. On average, analysts forecast that NVS's EPS will be $10.00 for 2027, with the lowest EPS forecast at $8.34, and the highest EPS forecast at $11.03. In 2028, NVS's EPS is forecast to hit $11.17 (min: $10.03, max: $13.34).

What is NVS's forecast return on equity (ROE) for 2026-2029?

(NYSE: NVS) forecast ROE is 47.88%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.